Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 11 1996, 706-709, Vol 3, No. 6
M Biendo, F Eb, JF Lefebvre and J Orfila
The Western blot (immunoblot) patterns of 56 serum specimens, all examined
previously by the microimmunofluorescence (MIF) test for species-specific
Chlamydia antibodies, were analyzed. Predominant specific-antibody activity
was directed to the 170-, 155-, 145-, 120-, 115-, 100-, 57-, and 38-kDa
proteins of Chlamydia trachomatis and to the 175-, 130-, 110-, 98-, and
30-kDa proteins of Chlamydia pneumoniae. All of these antigens appeared to
be species specific. The reactivity with 90-, 80-, 75-, 62- or 60-, and
55-kDa proteins and the major outer membrane protein appeared to be genus
specific. Fourteen serum samples which had identical titers of
immunoglobulin G as determined by the MIF test were investigated by Western
blotting. We found that nine serum samples had anti-C. trachomatis protein
profiles and two had anti-C. pneumoniae protein profiles. The double
seropositivity observed by MIF corresponded with cross-reactivity to
genus-specific antibodies. As for the three remaining serum specimens, we
observed identical protein profiles for C. trachomatis and C. pneumoniae,
confirming the double seropositivity experienced with the MIF test. Western
blotting can differentiate between specific reactions and interfering noise
from other, partly cross-reacting chlamydial species.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Limits of the microimmunofluorescence test and advantages of immunoblotting in the diagnosis of chlamydiosis
Laboratoire de Bacteriologie-Immunologie Generale, CHU Nord, France.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |